BioLineRX
(NASDAQ: BLRX)
|
5:00 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $0.53 | Change: -0.00 | %Change: -0.39% | Volume: 299,438 |
Open: | $ 0.54 | Volume: | 299,438 | |
---|---|---|---|---|
High: | $ 0.56 | Yield(%) | 0.00 | |
Low: | $ 0.51 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 42.37M | |
EPS ($) | -0.76 | Shares Out: | 79.94M |
% Price Change (last 4 weeks): | -23.86 |
---|---|
% Price Change (last 13 weeks): | -35.86 |
% Price Change (last 26 weeks): | -65.23 |
% Price Change (last 52 weeks): | -67.16 |
% Price Change (year to date): | -66.24 |
Return on Equity (%): | -189.23 |
---|---|
Return on Assets (%): | -86.40 |
Return on Invested Capital (%): | -77.43 |
Gross Profit Margin (%): | 3.62 |
---|---|
Net Profit Margin (%): | -1262.79 |
Operating Profit Margin (%): | -895.65 |
|
|
50-day Moving Average: | $0.65 |
---|---|
200-day Moving Average: | $1.20 |
Avg. Daily Vol. (last 50 days): | 329,022 |
Avg. Daily Vol. (last 200 days): | 424,959 |
52-wk high: | $2.53 |
52-wk low: | $0.52 |
Bid: | $0.52 |
Ask: | $0.58 |
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
|
BioLineRX
Modi'in Technology Park 2 HaMa'ayan Street Modi'in HM 7177871 Phone: 972.8.642.9100 Fax: 972.8.642.9101 http://www.biolinerx.com |
Earnings (1year) ($): | -0.76 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 0.18 |
Cash Flow ($): | -0.82 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 21.01 |
Price/Book (x): | 8.60 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 1.47 |
---|---|
Current Ratio (x): | 1.53 |
LT Debt/Equity (x): | 59.88 |
Total Debt/Equity (x): | 87.66 |